Alpha-2 receptor agonists for the treatment of posttraumatic stress disorder
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Clonidine and guanfacine are alpha-2 receptor agonists that decrease sympathetic outflow from the central nervous system. Posttraumatic stress disorder (PTSD) is an anxiety disorder that is theorized to be related to a hyperactive sympathetic nervous system. Currently, the only US Food and Drug Administration (FDA)-approved medications for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine. Sometimes use of the SSRIs may not lead to full remission and symptoms of hyperarousal often persist. This article specifically reviews the literature on alpha-2 receptor agonist use for the treatment of PTSD and concludes that while the evidence base is limited, these agents might be considered useful when SSRIs fail to treat symptoms of agitation and hyperarousal in patients with PTSD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder
Southwick, S. M., Bremner, J. D., Rasmusson, A., Morgan, C. A., Arnsten, A., & Charney, D. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00219-x · Cited by 573 · cited 2×
“Interestingly, these agents seem to be also utilized in patients with PTSD and other psychiatric disorders to help lower agitation [7].”
BackgroundPosttraumatic Stress Disorder in Adults: Impact, Comorbidity, Risk Factors, and Treatment
Sareen, J. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900902 · Cited by 467 · cited 3×
“Prevalence rates among these at-risk populations may be as high as 40% [2].”
BackgroundInfluentialCSF Norepinephrine Concentrations in Posttraumatic Stress Disorder
Geracioti, T. D., Baker, D. G., Ekhator, N. N., West, S. A., Hill, K. K., Bruce, A. B., Schmidt, D., Rounds-Kugler, B., Yehuda, R., Keck, P. E., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1227 · Cited by 462
Pharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis
Hoskins, M., Pearce, J., Bethell, A., Dankova, L., Barbui, C., Tol, W. A., van Ommeren, M., de Jong, J., Seedat, S., Chen, H., et al. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.148551 · Cited by 418
BLANCHARD, E. B., KOLB, L. C., PRINS, A., GATES, S., & McCOY, G. C. (1991) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199106000-00012 · Cited by 152 · cited 1×
“001), while the same stimuli lead to no significant change in plasma NE in healthy controls [16].”
BackgroundConnor, D. F., Grasso, D. J., Slivinsky, M. D., Pearson, G. S., & Banga, A. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0119 · Cited by 102 · cited 2×
“study chose to continue with GXR treatment [25].”
Background
Cited by
Modular organization of the brainstem noradrenaline system coordinates opposing learning states
Uematsu, A., Tan, B. Z., Ycu, E. A., Cuevas, J. S., Koivumaa, J., Junyent, F., Kremer, E. J., Witten, I. B., Deisseroth, K., & Johansen, J. P. (2017) · Nature Neuroscience · doi:10.1038/nn.4642 · Cited by 340
Revisiting propranolol and PTSD: Memory erasure or extinction enhancement?
Giustino, T. F., Fitzgerald, P. J., & Maren, S. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.01.009 · Cited by 137
Szeleszczuk, Ł., & Frączkowski, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710099 · Cited by 46
“Clonidine has been shown to alleviate nightmares and hyperarousal symptoms in patients with PTSD [172,176,183,184].”
BackgroundDoyle, M. A., Ling, S., Lui, L. M. W., Fragnelli, P., Teopiz, K. M., Ho, R., Di Vincenzo, J. D., Rosenblat, J. D., Gillissie, E. S., Nogo, D., et al. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2063273 · Cited by 27
Srour, H., Pandya, K., Flannery, A., & Hatton, K. (2018) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253218768537 · Cited by 21
Metadata
- Authors
- Belkin, M., & Schwartz, T.
- Venue
- Drugs in Context
- Publisher
- BioExcel
- Published
- 2015-08-14
- Volume
- 4
- Pages
- 1-5
- ISSN
- 1740-4398 (ISSN-L)
- OpenAlex
- W2402748048
- Cited by
- 57
- References
- 6
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alpha-2 receptor agonists for the treatment of posttraumatic stress disorder. https://app.cochat.ai/papers/10.7573/dic.212286
- The paper
- Belkin, M., & Schwartz, T. (2015). Alpha-2 receptor agonists for the treatment of posttraumatic stress disorder. Drugs in Context. https://doi.org/10.7573/dic.212286
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.